These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15238561)

  • 1. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
    Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
    J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for incompletely resected canine mast cell tumors.
    LaDue T; Price GS; Dodge R; Page RL; Thrall DE
    Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
    Weisse C; Shofer FS; Sorenmo K
    J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
    J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs.
    Turrel JM; Kitchell BE; Miller LM; Théon A
    J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
    Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
    J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
    Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
    J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
    Chaffin K; Thrall DE
    Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions data supporting conclusions on grade-III mast cell tumors.
    Schulman FY; Lipscomb TP
    J Am Vet Med Assoc; 2004 Feb; 224(4):501; author reply 501. PubMed ID: 14989538
    [No Abstract]   [Full Text] [Related]  

  • 12. Reirradiation of tumors in cats and dogs.
    Turrel JM; Théon AP
    J Am Vet Med Assoc; 1988 Aug; 193(4):465-9. PubMed ID: 3139592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993).
    Frimberger AE; Moore AS; LaRue SM; Gliatto JM; Bengtson AE
    J Am Anim Hosp Assoc; 1997; 33(4):320-4. PubMed ID: 9204467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
    Hahn KA; King GK; Carreras JK
    J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for canine mast cell tumors.
    Mayer MN
    Can Vet J; 2006 Mar; 47(3):263-5. PubMed ID: 16604985
    [No Abstract]   [Full Text] [Related]  

  • 17. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
    Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
    J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs.
    al-Sarraf R; Mauldin GN; Patnaik AK; Meleo KA
    J Vet Intern Med; 1996; 10(6):376-8. PubMed ID: 8947870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.